AR042694A1 - Derivados de imidazol y triazol inhibidores de cox-1, metodo de sintesis y composiciones farmaceuticas - Google Patents

Derivados de imidazol y triazol inhibidores de cox-1, metodo de sintesis y composiciones farmaceuticas

Info

Publication number
AR042694A1
AR042694A1 ARP030104881A ARP030104881A AR042694A1 AR 042694 A1 AR042694 A1 AR 042694A1 AR P030104881 A ARP030104881 A AR P030104881A AR P030104881 A ARP030104881 A AR P030104881A AR 042694 A1 AR042694 A1 AR 042694A1
Authority
AR
Argentina
Prior art keywords
cyano
imidazol
cox
inhibitors
pharmaceutical compositions
Prior art date
Application number
ARP030104881A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2002953602A external-priority patent/AU2002953602A0/en
Priority claimed from AU2003901804A external-priority patent/AU2003901804A0/en
Priority claimed from AU2003903928A external-priority patent/AU2003903928A0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of AR042694A1 publication Critical patent/AR042694A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de fórmula (1), en la cual R1 es alquilo inferior el cual está sustituido, en forma opcional, por sustituyente(s) adecuado(s); cicloalquilo inferior; alquinilo inferior; ciano; acilo; grupo heterocíclico, etc.; R2 es alquilo inferior, alcoxi inferior, ciano o 1H-pirrol-1-ilo; R3 es alquileno inferior o alquinileno inferior; R4 es hidroxi, hidroxi protegido, amino, amino protegido; acilamino, acilo, ciano o un grupo heterocíclico; X es O, S, SO o SO2; Y es CH o N; Z es CH o N; W es O, S, SO o SO2; m es 0 ó 1; n es 0 ó 1; y circulo A es triazol o imidazol; o sales del mismo, que son útiles como medicamentos para el tratamiento de afecciones inflamatorias, dolores, enfermedades del colágeno, enfermedades autoinmunes, trombosis, cáncer o enfermedades neurodegenerativas.
ARP030104881A 2002-12-30 2003-12-30 Derivados de imidazol y triazol inhibidores de cox-1, metodo de sintesis y composiciones farmaceuticas AR042694A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2002953602A AU2002953602A0 (en) 2002-12-30 2002-12-30 New compounds
AU2003901804A AU2003901804A0 (en) 2003-04-15 2003-04-15 New compounds
AU2003903928A AU2003903928A0 (en) 2003-07-28 2003-07-28 New compounds

Publications (1)

Publication Number Publication Date
AR042694A1 true AR042694A1 (es) 2005-06-29

Family

ID=32718317

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104881A AR042694A1 (es) 2002-12-30 2003-12-30 Derivados de imidazol y triazol inhibidores de cox-1, metodo de sintesis y composiciones farmaceuticas

Country Status (3)

Country Link
AR (1) AR042694A1 (es)
TW (1) TW200424197A (es)
WO (1) WO2004060367A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094407A1 (ja) * 2003-04-21 2004-11-04 Daiichi Pharmaceutical Co. Ltd. ５員複素環誘導体
CA2524889A1 (en) * 2003-05-08 2004-11-18 Astellas Pharma Inc. 1,2-diarylimidazoles useful as inhibitors of cox
WO2005095354A1 (en) 2004-04-03 2005-10-13 Astrazeneca Ab Therapeutic agents
RU2007118659A (ru) * 2004-10-19 2008-11-27 Дайити Фармасьютикал Ко., Лтд. (JP) Производное 1, 5-дигетероцикл-1н-триазола
JP2008526887A (ja) * 2005-01-10 2008-07-24 ユニバーシティ オブ コネチカット カンナビノイド受容体に作用する新規なヘテロピロール類似体
AT502258B1 (de) * 2005-07-22 2007-09-15 Univ Wien Cox-i-inhibitorverbindungen
EP2070908A4 (en) 2006-09-07 2011-08-10 Univ Okayama Nat Univ Corp COMPOUND HAVING A BENZAMIDE SKELETER AND A SELECTIVE CYCLOOXYGENASE INHIBITORY ACTIVITY (COX-1)
PE20110843A1 (es) 2008-09-22 2011-12-08 Cayman Chem Co Derivados de 5-(1h-imidazol-5-il)-2-fenilpirimidina, como inhibidores de prostaglandina d sintasa hematopoyetica
EA201590381A1 (ru) * 2012-08-16 2015-07-30 Янссен Фармацевтика Нв Замещенные пиразолы, используемые в качестве блокаторов кальциевых каналов n-типа
US9453002B2 (en) 2013-08-16 2016-09-27 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers
CN104415172A (zh) * 2013-09-09 2015-03-18 廖国建 一种治疗肩周炎的药物
CN108349904B (zh) 2015-10-07 2021-08-31 米托布里奇公司 Ppar激动剂、化合物、药物组合物及其使用方法
MX2018012538A (es) 2016-04-13 2019-02-25 Mitobridge Inc Agonistas del receptor activado por proliferador de peroxisoma (ppar), compuestos, composiciones farmaceuticas y metodos para usar los mismos.
EA039771B1 (ru) * 2016-06-20 2022-03-11 Митобридж, Инк. Агонисты ppar, соединения, фармацевтические композиции и способы их применения
CA3125847A1 (en) 2020-07-27 2022-01-27 Makscientific, Llc Process for making biologically active compounds and intermediates thereof
US12054480B2 (en) 2020-07-31 2024-08-06 Makscientific, Llc Compounds for treating cannabinoid toxicity and acute cannabinoid overdose
WO2024009283A1 (en) * 2022-07-07 2024-01-11 University Of Southern California At2 antagonists for non-addictive pain relief

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE346849T1 (de) * 1996-01-26 2006-12-15 Searle Llc Ein verfahren zur herstellung von 4- 2-(aryl oder heterocyclo)-1h-imidazol-1-ylöbenzolsulfonamide
EP1288206B1 (en) * 1996-04-12 2008-09-17 G.D. Searle LLC Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
EP1099695A1 (en) * 1999-11-09 2001-05-16 Laboratoire Theramex S.A. 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
AUPR878201A0 (en) * 2001-11-09 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. New compounds

Also Published As

Publication number Publication date
TW200424197A (en) 2004-11-16
WO2004060367A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
AR042694A1 (es) Derivados de imidazol y triazol inhibidores de cox-1, metodo de sintesis y composiciones farmaceuticas
DE60321808D1 (de) Flavon derivate als inhibitoren von cyclin-abhängigen kinasen
NO20060664L (no) N-substituerte benzimidazolyl C-kit inhibitorer
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
TW200526658A (en) Heterocyclic inhibitors of MEK and methods of use thereof
DE602004024799D1 (de) Synthese geschützter pyrrolobenzodiazepine
CR6565A (es) Pirimidina-2,4,6-trionas inhibidores de metloproteinas
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
PE20050338A1 (es) Compuestos de aminotriazoles como inhibidores de proteina quinasas
ATE405553T1 (de) Heterocyclische verbindungen als inhibitoren von faktor viia
MXPA05007352A (es) Compuestos triciclicos inhibidores de proteina quinasa para mejorar la eficacia de agentes antineoplasicos y terapia de radiacion.
ATE437872T1 (de) Proteinkinaseinhibitoren
PA8569301A1 (es) "derivados de bencimidazol n3 alquilado como inhibidores de mek" "n3 alkylated benzimidazole derivatives as mek inhibitors"
ATE461179T1 (de) Hemmer der akt aktivität
NO20074177L (no) Substituerte triazolderivater som oksytocinantagonister
PE20081169A1 (es) Compuestos tipo pirazol y triazol sustituidos como inhibidores de ksp
DE60311646D1 (de) 1-substituierten imidazol derivaten als nos inhibitoren
AR022019A1 (es) Un compuesto de imidazol y las composiciones farmaceuticas que lo contienen
AU2003250471A8 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
PT1601646E (pt) Análogos da vitamina d e suas utilizações terapêuticas
EA200500899A1 (ru) Антагонисты аденозиндифосфатного рецептора тромбоцитов
AR055666A1 (es) Inhibidores inntr
AR038276A1 (es) Metodos para incrementar la formacion osea.
MX2009002998A (es) Derivado de pirazolopirimidina.
AR037347A1 (es) Derivados de triazol

Legal Events

Date Code Title Description
FB Suspension of granting procedure